SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000899866-18-000022
Filing Date
2018-02-08
Accepted
2018-02-08 16:26:33
Documents
161
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K alxn10k12312017.htm 10-K 3244932
2 EMPLOYMENT AGREEMENT alxnex10612312017.htm EX-10.6 108077
3 FORM OF 2017 INCENTIVE PLAN RESTRICTED STOCK UNIT AGREEMENT alxnex103212312017.htm EX-10.32 43778
4 FORM OF 2017 INCENTIVE PLAN NONQUALIFIED STOCK OPTION AGREEMENT alxnex103312312017.htm EX-10.33 43588
5 FORM OF 2017 INCENTIVE PLAN PERFORMANCE STOCK UNIT AGREEMENT (TSR) alxnex103412312017.htm EX-10.34 33945
6 FORM OF 2017 INCENTIVE PLAN PERFORMANCE STOCK UNIT AGREEMENT (R&D UNITS) alxnex103512312017.htm EX-10.35 58769
7 2017 INCENTIVE PLAN RULES FOR AWARDS GRANTED TO PARTICIPANTS IN FRANCE alxnex103612312017.htm EX-10.36 56482
8 FORM OF 2017 INCENTIVE PLAN RESTRICTED STOCK UNIT AGREEMENT FOR FRENCH PARTICIPA alxnex103712312017.htm EX-10.37 68549
9 FORM OF 2017 INCENTIVE PLAN GLOBAL STOCK OPTION AGREEMENT alxnex103812312017.htm EX-10.38 80856
10 FORM OF 2017 INCENTIVE PLAN RESTRICTED STOCK UNIT AGREEMENT FOR NON-US PARTICIPA alxnex103912312017.htm EX-10.39 167521
11 SUBSIDIARIES OF ALEXION PHARMACEUTICALS, INC. alxnex21112312017.htm EX-21.1 13511
12 CONSENT OF PRICEWATERHOUSECOOPERS LLP alxnex23112312017.htm EX-23.1 3019
13 CERTIFICATION OF CEO PURSUANT TO SECTION 302 alxnex31112312017.htm EX-31.1 13442
14 CERTIFICATION OF CFO PURSUANT TO SECTION 302 alxnex31212312017.htm EX-31.2 13600
15 CERTIFICATION OF CEO PURSUANT TO SECTION 906 alxnex32112312017.htm EX-32.1 7187
16 CERTIFICATION OF CFO PURSUANT TO SECTION 906 alxnex32212312017.htm EX-32.2 7089
23 accumclinicalspend17.jpg GRAPHIC 27422
24 acquisitioncosts17.jpg GRAPHIC 11350
25 alawalxn.jpg GRAPHIC 41252
26 alexionlogoa08.jpg GRAPHIC 15115
27 briangoffalxn.jpg GRAPHIC 43993
28 consnetproductsales17.jpg GRAPHIC 29695
29 contingentconsideration17.jpg GRAPHIC 11484
30 cos17.jpg GRAPHIC 14108
31 incometaxes17.jpg GRAPHIC 20583
32 indranifranchinialxn.jpg GRAPHIC 44551
33 intangibleimpairment17.jpg GRAPHIC 8637
34 jmoriartyalxn.jpg GRAPHIC 41655
35 johnorloffalxn.jpg GRAPHIC 40897
36 julieoneillalxn.jpg GRAPHIC 30381
37 kanuma-logo.jpg GRAPHIC 14690
38 kanumanetproductsales17.jpg GRAPHIC 16836
39 ludwighanstonalxn.jpg GRAPHIC 31211
40 otherincomeexp17.jpg GRAPHIC 25066
41 pclancyalxn.jpg GRAPHIC 36119
42 purchasedintangibleamort17.jpg GRAPHIC 12803
43 pvfx16.jpg GRAPHIC 11263
44 pvfx17.jpg GRAPHIC 11560
45 rdclinical17.jpg GRAPHIC 53009
46 rdcosts17.jpg GRAPHIC 35602
47 restructuringexpenses17.jpg GRAPHIC 11229
48 sgacosts17.jpg GRAPHIC 22740
49 soliris-logo.jpg GRAPHIC 13770
50 solirisnetproductsales17.jpg GRAPHIC 29193
51 strensiq-logo.jpg GRAPHIC 12778
52 strensiqnetproductsales17.jpg GRAPHIC 19298
53 totalreturngraph2017.jpg GRAPHIC 60637
54 wagnerhalxn.jpg GRAPHIC 26975
  Complete submission text file 0000899866-18-000022.txt   18861008

Data Files

Seq Description Document Type Size
17 XBRL INSTANCE DOCUMENT alxn-20171231.xml EX-101.INS 4110643
18 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alxn-20171231.xsd EX-101.SCH 94212
19 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT alxn-20171231_cal.xml EX-101.CAL 165501
20 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT alxn-20171231_def.xml EX-101.DEF 715990
21 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alxn-20171231_lab.xml EX-101.LAB 1397060
22 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alxn-20171231_pre.xml EX-101.PRE 929772
Mailing Address 100 COLLEGE STREET NEW HAVEN CT 06510
Business Address 100 COLLEGE STREET NEW HAVEN CT 06510 2032722596
ALEXION PHARMACEUTICALS INC (Filer) CIK: 0000899866 (see all company filings)

IRS No.: 133648318 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-27756 | Film No.: 18586098
SIC: 2834 Pharmaceutical Preparations